- Home
- ICG vs NRXS Comparison
ICG vs NRXS Comparison
Compare ICG & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICG | NRXS |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 78.9M |
| IPO Year | 2022 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ICG | NRXS |
|---|---|---|
| Price | $0.75 | $7.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.25 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 120.1K | 115.9K |
| Earning Date | 05-21-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | N/A | $172.91 |
| Revenue Next Year | N/A | $115.71 |
| P/E Ratio | $6.80 | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $0.60 | $2.20 |
| 52 Week High | $3.22 | $9.33 |
Technical Indicators
Market Signals| Indicator | ICG | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 37.33 | 50.93 |
| Support Level | $0.64 | $6.92 |
| Resistance Level | $1.36 | $7.79 |
| Average True Range (ATR) | 0.08 | 0.38 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 22.86 | 73.83 |
Price Performance
Historical ComparisonAbout ICG Intchains Group Limited
Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).